Pharmacokinetic Study of Lidocaine Patch 1.8% Lidocaine Patch 5% (Lidoderm®) in Healthy Subjects

NCT04144192 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Lidocaine patch 1.8%
DRUG: Lidocaine 5% patch
DRUG: Lidocaine 2% Injectable Solution

Sponsor

Scilex Pharmaceuticals, Inc.